[{"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90512", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1249-2022", "product_description": "Bupivacaine HCl 150 mg (3.0 mg/mL), Ketorolac Tromethamine 60 mg (1.2 mg/mL), Ketamine HCl 60 mg (1.2 mg/mL) Injection, 50 mL syringes, packaged in 5 x 50 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-514-50", "product_quantity": "2315 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220630", "center_classification_date": "20220718", "termination_date": "20240617", "report_date": "20220727", "code_info": "Lots: BP2001A, Exp. 7/6/2022; BP2002A, Exp. 7/27/2022; BP2007A, Exp. 7/3/2022"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0764-2019", "product_description": "Dr. King's SafeCare Rx Aller-Detox: Water Chemicals U.S., 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955340027, NDC 57955-3400-2", "product_quantity": "17 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 022516A Exp. 02/19"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0209-2023", "product_description": "GENTAMICIN BLADDER 0.08MG/ML (60ML SYRINGE) IRRIGATION; GENTAMICIN BLADDER 0.48MG/ML (30ML SYRINGE) IRRIGATION; GENTAMICIN BLADDER 0.48MG/ML (60ML SYRINGE) IRRIGATION; GENTAMICIN BLADDER 0.64MG/ML (25ML SYRINGE) IRRIGATION; GENTAMICIN BLADDER 0.64MG/ML (25ML SYRINGE) IRRIGATION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221117@11 t20221116@36 t20221011@36 t20221108@24 t20221125@30 t20221020@64", "more_code_info": ""}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0758-2018", "product_description": "Xolair 150 mg SDV NDC 50242-0040-62 28 days", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204170"], "brand_name": ["ZOLPIDEM TARTRATE"], "generic_name": ["ZOLPIDEM TARTRATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-307", "47335-308"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ZOLPIDEM TARTRATE"], "rxcui": ["854880", "854894"], "spl_id": ["4a5c474b-e752-4d01-be37-a66e7c9bf62e"], "spl_set_id": ["0c64bc71-2e7f-4b15-a8e1-acb8de04395f"], "package_ndc": ["47335-307-88", "47335-307-13", "47335-308-88", "47335-308-13"], "is_original_packager": [true], "upc": ["0347335307887", "0347335308884"], "unii": ["WY6W63843K"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0272-2024", "product_description": "Zolpidem Tartrate Extended-Release Tablets, USP 12.5mg, Rx Only, 100 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), INDIA, NDC 47335-308-88.", "product_quantity": "14,568 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #: DNE0893A Expires 07/31/2026"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212730"], "brand_name": ["PIRFENIDONE"], "generic_name": ["PIRFENIDONE"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-467", "16729-468"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PIRFENIDONE"], "rxcui": ["1868014", "1868018"], "spl_id": ["23a823f0-33b8-94d7-e063-6394a90a345a"], "spl_set_id": ["fab59395-1c5d-4c64-ba47-34d75736e983"], "package_ndc": ["16729-467-15", "16729-467-85", "16729-467-64", "16729-468-15", "16729-468-64"], "is_original_packager": [true], "nui": ["N0000191420", "M0018236"], "pharm_class_epc": ["Pyridone [EPC]"], "pharm_class_cs": ["Pyridones [CS]"], "unii": ["D7NLD2JX7U"], "upc": ["316729467155", "316729467858"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0419-2023", "product_description": "Pirfenidone Tablets 267 mg 90-count bottle x3/Carton, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA. Bottle NDC 16729-467-15, UPC 3 16729 46715 5; Carton NDC 16729-467-85, UPC 3 16729 46785 8.", "product_quantity": "2614 cartons", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: P2202518, P2202512, Exp. Date 4/30/2024,  P2204588, P2204589, Exp. Date 7/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0826-2022", "product_description": "Hydroxocobalamin B12, 1 mg/mL, 30 mL Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0080-30.", "product_quantity": "6431 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: D48026 BUD: 4/26/2022, E48025 BUD: 5/25/2022, G48B21 BUD: 7/21/2022, G48C21  BUD: 7/21/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Ringwood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78098", "recalling_firm": "Inopak Ltd", "address_1": "24 Executive Pkwy", "address_2": "N/A", "postal_code": "07456-1430", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide", "recall_number": "D-0002-2018", "product_description": "Option Systems Antibacterial Foaming Hand Wash, 0.3% P.C.M.X., 8 fl oz and 18 fl oz. bottles and 500, mL 800 mL, and 1000 mL pouches, ALSO labeled as STYLE Antibacterial Hand Soap, Inopak Ltd Ringwood, NJ --- NDC 5031-431-02", "product_quantity": "N/A", "reason_for_recall": "GMP Deviations; potential bacterial contamination may have been introduced to products through a contaminated diaphragm pump", "recall_initiation_date": "20170823", "center_classification_date": "20171004", "termination_date": "20200420", "report_date": "20171011", "code_info": "Batch Numbers \u0013 6718, 6730, 6744, 6754, 6760, 6773, 6784, 6793, 6804, 6812, 6819, 6838, 6846, 6862, 6877, 6890, 6902, 6910, 6919, 6838, 6846, 6862, 6877, 6890, 6902, 6910, 6919, 6938, 6944,    Style  Batch Numbers \u0013 6725, 6732, 6735, 6742, 6756, 6762, 6766, 6770, 6777, 6792, 6798, 6807, 6813, 6816, 6829, 6839, 6868, 6872, 6875, 6891, 6904, 6906, 6914, 6916, 6923, 6932, 6939, 6820", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77191", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0916-2017", "product_description": "VANCOMYCIN HCl 1.5g in 300 mL 5% Dextrose Injection USP, Service Code 2K2227, NDC# 61553-027-34, Total Volume 300.00 mL incorrectly labeled as 500.00 mL, Rx Only, PharMEDium Services, LLC, 12620 W. Airport Blvd #130, Sugar Land, TX 74478", "product_quantity": "108 bags", "reason_for_recall": "Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.", "recall_initiation_date": "20170217", "center_classification_date": "20170612", "termination_date": "20170613", "report_date": "20170621", "code_info": "Lot Numbers:   170250124S, 2/25/2017; 170270018S, 2/28/2017; 170380015S, 3/10/2017"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "1150 vials", "code_info": "Lot #: 13011450GV4, 13011450GV1, Exp 4/14/2013; 13011760B, Exp 4/17/2013; 13012450, Exp 4/24/2013; 13021960GV2, Exp 5/19/2013; 2013021950GV2, Exp 5/19/2013; 20130222GV3, Exp 5/22/2013; 13020450GV3, Exp 5/4/2013; 13020850GV2, Exp 5/8/2013; 13031330GV2, Exp 6/13/2013; 13032730GV1, Exp 6/27/2013; 20130327GV2, Exp 6/27/2013; 1303031475GV2, Exp 6/3/2013; 130301100GV2, Exp 6/1/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Bupivacaine and Dexamethasone Injection, all strengths and all presentations including Bupiv_Dexameth-0.25-10.5; Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-351-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 112 mcg may have potentially been mislabeled as the following drug:  RALTEGRAVIR, Tablet, 400 mg, NDC 00006022761, Pedigree: AD60272_19, EXP: 5/22/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "LEVOTHYROXINE SODIUM, Tablet, 112 mcg has the following codes:   Pedigree: AD60272_22, EXP: 5/22/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LEVOTHYROXINE SODIUM, Tablet, 112 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00527134601.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-922-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Lawrence", "state": "KS", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89879", "recalling_firm": "Plastikon Healthcare LLC", "address_1": "3780 Greenway Cir", "address_2": "N/A", "postal_code": "66046-5440", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed in Indiana for further distribution in the USA.", "recall_number": "D-0867-2022", "product_description": "MILK OF MAGNESIA USP, (Magnesium Hydroxide), 2400 mg/30 mL, 30 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Distributed by Major Pharmaceuticals, Livonia, MI 48152, NDC 0904-6846-73.", "product_quantity": "14,100 Unit Dose cups", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "recall_initiation_date": "20220324", "center_classification_date": "20220513", "report_date": "20220525", "code_info": "Lot: 20024A, 20025A, EXP Mar 2022", "more_code_info": ""}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0626-2023", "product_description": "Piperacillin and Tazobactam for Injection, USP, 2.25 grams per vial, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017, NDC66794-216-41", "product_quantity": "112,640 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["BASIC CARE NO DRIP NASAL"], "generic_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "manufacturer_name": ["Amazon.com Services LLC"], "product_ndc": ["72288-388"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "rxcui": ["1000990"], "spl_id": ["b6f50e61-ad28-417f-8ede-e543084f4ab3"], "spl_set_id": ["96e018e2-e0b5-4802-a4a1-73a73d574082"], "package_ndc": ["72288-388-10"], "is_original_packager": [true], "unii": ["K89MJ0S5VY"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0613-2022", "product_description": "Maximum Strength No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant,  1 FL Oz (30 mL) per bottle,  DISTRIBUTED BY: AMAZON.COM SERVICES LLC, 410 TERRY AVENUE N. SEATTLE, WA 9810. NDC 72288-388-10", "product_quantity": "1,296 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1BK0964R, Exp 01/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Wilmington", "state": "MA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA090533"], "brand_name": ["ZENZEDI"], "generic_name": ["DEXTROAMPHETAMINE SULFATE"], "manufacturer_name": ["AZURITY PHARMACEUTICALS, INC."], "product_ndc": ["24338-850", "24338-851", "24338-852", "24338-853", "24338-854", "24338-855", "24338-856"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DEXTROAMPHETAMINE SULFATE"], "rxcui": ["884385", "884386", "884684", "1425337", "1425339", "1425847", "1425854", "1426251", "1426253", "1535451", "1535454", "1535456", "1535470", "1535472"], "spl_id": ["3777ce80-1fa3-6f52-e063-6294a90a3c51"], "spl_set_id": ["d6394df5-f2c9-47eb-b57e-f3e9cfd94f84"], "package_ndc": ["24338-850-03", "24338-851-03", "24338-852-03", "24338-853-03", "24338-854-03", "24338-855-03", "24338-856-03"], "is_original_packager": [true], "upc": ["0324338854037", "0324338852033", "0324338850039", "0324338853030", "0324338856031", "0324338851036"], "unii": ["JJ768O327N"]}, "product_type": "Drugs", "event_id": "93786", "recalling_firm": "Azurity Pharmaceuticals, Inc.", "address_1": "841 Woburn St", "address_2": "", "postal_code": "01887-3414", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0323-2024", "product_description": "Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals, LLC., Atlanta, Georgia, 30328, NDC 24338-856-03", "product_quantity": "4,662 bottles", "reason_for_recall": "Labeling: Label Mix-up", "recall_initiation_date": "20240104", "center_classification_date": "20240212", "termination_date": "20240918", "report_date": "20240207", "code_info": "Lot # F230169A, Exp. 06/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021537"], "brand_name": ["CIPROFLOXACIN AND DEXAMETHASONE"], "generic_name": ["CIPROFLOXACIN AND DEXAMETHASONE"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-6186"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["AURICULAR (OTIC)"], "substance_name": ["CIPROFLOXACIN HYDROCHLORIDE", "DEXAMETHASONE"], "rxcui": ["403908"], "spl_id": ["39a8b845-aa32-4c9d-bef8-18cea1ef7bc9"], "spl_set_id": ["89fef4d2-7078-47f1-96bf-aca50b135a97"], "package_ndc": ["0781-6186-67"], "is_original_packager": [true], "upc": ["0307816186677"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["4BA73M5E37", "7S5I7G3JQL"]}, "product_type": "Drugs", "event_id": "97431", "recalling_firm": "Sandoz Inc", "address_1": "100 College Rd W", "address_2": "N/A", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to one consignee in CA.", "recall_number": "D-0626-2025", "product_description": "Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Novartis Manufacturing NV, Belgium, Distributed by: Sandoz, Inc., Princeton, NJ,  NDC# 0781-6186-67, Carton NDC# 0781-6186-67", "product_quantity": "1,680 bottles", "reason_for_recall": "Temperature Abuse", "recall_initiation_date": "20250813", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Lot # VNF35A, Exp.08/31/2026"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63871", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-130-2013", "product_description": "Lisinopril Tablets, USP 40 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1270-01); b) 1000-count tablets per bottle (NDC 0143-1270-10); Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ  07724; and c) 1000-count tablets per bottle (NDC 24658-245-10); Rx only, Manufactured for: Blu Pharmaceuticals, Franklin, KY 42134; Manufactured By: West-ward Pharmaceutical Corp., Eatontown, N.J. 07724.", "product_quantity": "32,550 bottles", "reason_for_recall": "Presence of Foreign Substance: Uncharacteristic black spots identified as a food grade lubricant with trace amounts of foreign particulates and stainless steel inclusions have been found in the tablets.", "recall_initiation_date": "20121207", "center_classification_date": "20130118", "termination_date": "20140804", "report_date": "20130130", "code_info": "Lot #: a) and b) 69545A, 69546A, 69546B, Exp 10/15; 69547A, Exp 11/15; 69995A, 69999A, 69999B, 70000A, 70001A, 70002A, 70002B, 70003A, 70004A, Exp 02/16; c) 69548A, 69549A, Exp 11/15; 69877A, Exp 02/16"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-479-2013", "product_description": "HCG Inj 500un/ml MDV, 5 ml  Subcutaneous, 30 day expiration,", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84122", "recalling_firm": "Sanofi-Aventis U.S. LLC", "address_1": "55 Corporate Dr", "address_2": "", "postal_code": "08807-1265", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0540-2020", "product_description": "Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC 50269-222-25.", "product_quantity": "", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191022", "center_classification_date": "20191201", "report_date": "20191211", "code_info": "all lots", "more_code_info": ""}, {"status": "Terminated", "city": "South San Francisco", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["BLA761197"], "brand_name": ["SUSVIMO"], "generic_name": ["RANIBIZUMAB"], "manufacturer_name": ["Genentech, Inc."], "product_ndc": ["50242-078"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVITREAL"], "substance_name": ["RANIBIZUMAB"], "rxcui": ["2584857", "2584863"], "spl_id": ["2ffa1867-28d5-460f-b4ab-f9c837aa27ec"], "spl_set_id": ["9c6d9e2a-9a77-4d11-b692-de87cfde3444"], "package_ndc": ["50242-078-12", "50242-078-55", "8100425900", "0081004259"], "is_original_packager": [true], "nui": ["N0000193542", "N0000193543"], "pharm_class_moa": ["Vascular Endothelial Growth Factor Inhibitors [MoA]"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "unii": ["ZL1R02VT79"]}, "product_type": "Drugs", "event_id": "90959", "recalling_firm": "Genentech Inc", "address_1": "1 Dna Way", "address_2": "N/A", "postal_code": "94080-4918", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0025-2023", "product_description": "Susvimo (ranibizumab injection), 100mg/mL, sold together as a) carton containing One Susvimo single-dose vial and One Susvimo initial fill needle, NDC 50242-078-55; and b) carton labeled as Susvimo Ocular Implant with Insertion Tool Assembly, containing One carrier with implant and One insertion Tool, UDI 81004259001, GTIN 00810042590014, Rx only, Genentech, Inc., A Member of the Roche Group, South San Francisco, CA  94080-4990.", "product_quantity": "452 vials and implants", "reason_for_recall": "Defective Delivery System: Commercial implants do not meet the filed specification for the intended use, a few patients have experienced an issue with the implants that renders it non-functioning.", "recall_initiation_date": "20221018", "center_classification_date": "20221101", "termination_date": "20240417", "report_date": "20221109", "code_info": "Lot/Exp: a) 3499188, Exp 10/31/2022; Lot 3523071, Exp 6/30/2023; b) 3456735, Exp 10/23/2026; 3456737; Exp 10/29/2026; 3477671, Exp 10/31/2026; 3480781, Exp 12/19/2026; 3506526, Exp 02/25/2027; 3506531, Exp 04/15/2027"}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89059", "recalling_firm": "SterRx, LLC", "address_1": "141 Idaho Ave", "address_2": "", "postal_code": "12903-3987", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0321-2022", "product_description": "NOREPINEPHRINE, 8 mg per 250 mL, (32 mcg per mL) in 0.9% Sodium Chloride Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-676-01.", "product_quantity": "74,508 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211112", "center_classification_date": "20211229", "termination_date": "20231206", "report_date": "20220105", "code_info": "S21162/BTT 13-Nov-21  S21163/BTU 13-Nov-21  S21167/BTY 19-Nov-21  S21174/BUF 20-Nov-21  S21175/BUG 21-Nov-21  S21217/BVS 12-Dec-21  S21218/BVT 12-Dec-21  S21219/BVU 16-Dec-21  S21241/BWL 24-Dec-21  S21281/BXY 20-Jan-22  S21282/BXZ 23-Jan-22  S21283/BYA 22-Jan-22  S21297/BYN 28-Jan-22  S21340/CAA 27-Feb-22  S21342/CAC 5-Mar-22  S21352/CAL 6-Mar-22  S21359/CAS 11-Mar-22  S21362/CAV 12-Mar-22  S21368/CBB 13-Mar-22  S21369/CBC 19-Mar-22  S21415/CCX 7-Apr-22  S21419/CDB 7-Apr-22  S21434/CDP 16-Apr-22", "more_code_info": ""}, {"status": "Terminated", "city": "Elizabeth", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67053", "recalling_firm": "Actavis Elizabeth LLC", "address_1": "200 Elmora Ave", "address_2": "", "postal_code": "07202-1106", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1087-2014", "product_description": "Clonazepam Tablets, USP 2 mg 100 tablets Manufactured by: Actavis Elizabeth LLC 200 Elmora Avenue, Elizabeth, NJ 0737 USA  NDC 0228-3005-11    packaged in White/Round HDPE 75 CC with white/round plastic 33 mm CRC closure shipped in corrugated 75 cc carton (24 bottles/carton)", "product_quantity": "13,608 bottles", "reason_for_recall": "Subpotent Drug: During routine stability testing one tablet was found with tablet weight below specification.", "recall_initiation_date": "20131106", "center_classification_date": "20140221", "termination_date": "20140602", "report_date": "20140305", "code_info": "lot 58468552 Exp. 05/15", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0181-2024", "product_description": "FIRST LANSOPRAZOLE PT 3MG/ML, 300ML, Rx Only, Distributed By:  CutisPharma, Inc., Woburn, MA 01801.  NDC: 65628-080-10", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 21025A", "more_code_info": ""}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202230"], "brand_name": ["LOSARTAN POTASSIUM"], "generic_name": ["LOSARTAN POTASSIUM"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-044", "33342-045", "33342-046"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LOSARTAN POTASSIUM"], "rxcui": ["979480", "979485", "979492"], "spl_id": ["81824d1f-61f4-457c-8723-cd43d5429029"], "spl_set_id": ["85d69d02-c5ef-467e-94aa-903100218795"], "package_ndc": ["33342-044-10", "33342-044-12", "33342-044-07", "33342-044-44", "33342-045-10", "33342-045-12", "33342-045-07", "33342-045-44", "33342-046-10", "33342-046-12", "33342-046-07", "33342-046-44"], "is_original_packager": [true], "unii": ["3ST302B24A"]}, "product_type": "Drugs", "event_id": "90037", "recalling_firm": "Macleods Pharma Usa Inc", "address_1": "666 Plainsboro Rd Bldg 200 Ste 230", "address_2": "N/A", "postal_code": "08536-0009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0832-2022", "product_description": "Losartan Potassium Tablets, USP, 25 mg, a) 90-count bottles (NDC # 33342-044-10), b) 1000-count bottles (NDC # 33342-044-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536", "product_quantity": "12,408/90 count bottles; 1670/1000 count bottles =2,786,720 tablets", "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits", "recall_initiation_date": "20220415", "center_classification_date": "20220503", "termination_date": "20231013", "report_date": "20220511", "code_info": "Lot #  BLH2002A, exp. date 11/2022  BLH2003B, exp. date 11/2022  BLH2004A, exp. date 11/2022"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77725", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0983-2017", "product_description": "Buprenorphine and Naloxone Sublingual Tablets, 2 mg/0.5 mg 30 tablets per bottle, Rx only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5720-56", "product_quantity": "25264 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:  out of specification test results for related compounds largest unknown impurity.", "recall_initiation_date": "20170629", "center_classification_date": "20170714", "termination_date": "20180426", "report_date": "20170726", "code_info": "Lot #:  30227613A, 30227614A, 30227615A, EXP 6/2017; 30228559A, 30228560A, EXP 9/2017; 3000123, EXP 7/2018"}, {"country": "United States", "city": "Fort Worth", "address_1": "4201 Diplomacy Rd", "reason_for_recall": "Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.", "address_2": "", "product_quantity": "5363 tubes", "code_info": "Lot #: 131965, Exp 12/2018; 127426 Exp. 01/2019; 129045, 130424 Exp. 06/2019; 130432 Exp. 10/2019; 131870 Exp. 06/2019; 132648, Exp. 03/2020; 133732 Exp. 04/2020; 134400 Exp. 02/2020; 135345 Exp. 08/2020", "center_classification_date": "20181220", "distribution_pattern": "United States, Maldives, Canada, United Arab Emirates, and New Zealand", "state": "TX", "product_description": "Advanced Protection Sunscreen spf 30 (Octinoxate 7.5%, Octisalate 5%, Oxybenzone 6%), 4.5 Oz/127.5 g tube.", "report_date": "20181226", "classification": "Class III", "openfda": {}, "recalling_firm": "CBI Laboratories, Inc.", "recall_number": "D-0341-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81775", "termination_date": "20200114", "more_code_info": "", "recall_initiation_date": "20181210", "postal_code": "76155-2633", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Englewood", "address_1": "8591 Prairie Trail Dr Ste C600", "reason_for_recall": "cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.", "address_2": "", "product_quantity": "3,825 grams", "code_info": "Lot #: 18K26-BB02-PR00553, Reassay 10/09/2023  Product # 700365, 700362 & 700363", "center_classification_date": "20200416", "distribution_pattern": "USA Nationwide", "state": "CO", "product_description": "Estradiol, USP (Non-Micronized) (Hemihydrate), packaged in: a) 500 grams (NDC 63275-9900-8), b) 100 grams (NDC 63275-9900-5), c) 25 grams (NDC 63275-9900-4), Distributed by B&B Pharmaceuticals, Inc. 800-499-3100", "report_date": "20200422", "classification": "Class II", "openfda": {}, "recalling_firm": "B & B Pharmaceuticals, Inc.", "recall_number": "D-1244-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "85440", "termination_date": "20200724", "more_code_info": "", "recall_initiation_date": "20200414", "postal_code": "80112-7075", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0394097", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LIDOCAINE/SODIUM BICARBONATE/HEPARIN  IRRIGATION  10.6MG/16.8MG/2667U/ML SOLUTIO\t90 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1562-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Albany", "state": "OR", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "89152", "recalling_firm": "Dental Alliance Holdings LLC", "address_1": "812 Water Ave Ne", "address_2": "", "postal_code": "97321-3074", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed nationwide with the United States", "recall_number": "D-0455-2022", "product_description": "CTx21 Kit,  contains three tubes of CariFree CTx4 Gel 5000, 1.1% Neutral Sodium Fluoride Mint, 2 oz (57 g) Rx only NDC: 61578-205-01 Manufactured by Oral BioTech Albany, Oregon 97321 and three bottles of CariFree CTx3 Rinse, Mint Anticavity Rinse, 16 fl oz. bottle.", "product_quantity": "180 single tube of lot 272109 and 180 single tube count of lot 272110", "reason_for_recall": "Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.", "recall_initiation_date": "20211203", "center_classification_date": "20220126", "termination_date": "20220811", "report_date": "20220202", "code_info": "Lot #: 272109, 272110 Exp. Date 06/22;  (contains recalled CariFree CTx4 5000 gel tube lot 142017)", "more_code_info": ""}, {"country": "United States", "city": "East Brunswick", "address_1": "1 Tower Center Blvd Ste 1700", "reason_for_recall": "Lack of Assurance of Sterility: complaints received about dried powder on the outside of bottle", "address_2": "", "product_quantity": "5,060 units", "code_info": "Lot #: VCIA082, Exp. MAY 2020; VCIA083, VCIA084, Exp. JUNE 2020", "center_classification_date": "20190108", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Cidofovir Injection 375mg/5mL (75mg/mL) vial injection. 5 mL vials, Rx only, Mfd by: Emcure Pharmaceuticals Ltd., Hinjawadi, Pune, India  Mfg. for : Heritage Pharmaceuticals Inc. NDC 23155-0216-31", "report_date": "20190116", "classification": "Class II", "openfda": {}, "recalling_firm": "Heritage Pharmaceuticals, Inc.", "recall_number": "D-0352-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81896", "termination_date": "20210219", "more_code_info": "", "recall_initiation_date": "20190102", "postal_code": "08816-1145", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0196-2019", "product_description": "Trimix 30-1-30 Papavarin 30 mg/Phentolamine 1 mg/Alprostadil 30 mg/mL Aqueous Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-1319-10", "product_quantity": "50 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 06192018:98 Discard by: 12/16/2018"}, {"status": "Terminated", "city": "Millerton", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77526", "recalling_firm": "Phillips Co.", "address_1": "311 Chikasaw Street", "address_2": "N/A", "postal_code": "74750", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and United Kingdom", "recall_number": "D-0952-2017", "product_description": "VenomX, Zinc acetate (.1% by volume), 0.3 fl. oz. (3 mL) bottles, Skin Protectant Phillips Company, Millerton, OK --  NDC 43074-207-01", "product_quantity": "20-50 bottles/units", "reason_for_recall": "GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.", "recall_initiation_date": "20170608", "center_classification_date": "20170706", "termination_date": "20200720", "report_date": "20170712", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Ridgefield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "74046", "recalling_firm": "Genzyme Corporation / Genzyme Biosurgery", "address_1": "1125 Pleasantview Ter", "address_2": "", "postal_code": "07657-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MI, PA & NJ", "recall_number": "D-1029-2016", "product_description": "Hectorol (doxercalciferol injection) 2 mcg/1mL, Rx only,  Manufactured by: Genzyme Biosurgery Corporation 500 Kendall Street, Cambridge, MA 02142, NDC 58468-0126-1", "product_quantity": "2350 vials", "reason_for_recall": "Labeling: Wrong barcode. An incorrect bar code was noted on the vial label of Hectorol 2 mcg/1mL vial.", "recall_initiation_date": "20160427", "center_classification_date": "20160610", "termination_date": "20170623", "report_date": "20160622", "code_info": "Lot #: 6R1001, Exp. 12/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-951-2015", "product_description": "Vecuronium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "50 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "4000 mL in Vials", "code_info": "Lot #: 151220-4, BUD: 06/17/16;  Lot #: 160216-31, BUD: 08/14/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "B-COMPLEX 50 IN NACL 0.9% W/PRES., (BENZYL ETOH 2%), B1-50MG, B2-5-PO4-5MG, B3-50MG, B5-50MG, B6-50MG/ML, 10ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1173-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87547", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to MD, CO & TX only", "recall_number": "D-0323-2021", "product_description": "LCL-2-0191, 5 gallon carboys, Rx only, Manufactured for: LaCore Labs, LLC, by: Washington Homeopathic Products, Inc.260 J R Hawvermale Way Berkeley Springs West Virginia 25411", "product_quantity": "300 liters", "reason_for_recall": "An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.", "recall_initiation_date": "20210318", "center_classification_date": "20210405", "termination_date": "20210513", "report_date": "20210414", "code_info": "Lot # 28506"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077662"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-126", "68462-127"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "rxcui": ["310433", "310434"], "spl_id": ["5c6de7e2-6f75-426a-a832-5cea5c70b43e"], "spl_set_id": ["3865a6e3-112c-490c-82ac-35401336b16e"], "package_ndc": ["68462-126-01", "68462-126-05", "68462-127-01", "68462-127-05"], "is_original_packager": [true], "upc": ["0368462127018", "0368462126011"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0320-2025", "product_description": "Gabapentin Tablets 600mg, 500-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-126-05.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot # 17231015, exp. date Apr-25 17231128, exp. date Apr-25 17231138, exp. date Apr-25 17231139, exp. date Apr-25 17231143, exp. date Apr-25 17231144, exp. date Apr-25 17231848, exp. date Aug-25 17231898, exp. date Aug-25 17231977, exp. date Aug-25 17231978, exp. date Aug-25 17232015, exp. date Aug-25 17232016, exp. date Aug-25 17232017, exp. date Aug-25 17232034, exp. date Aug-25 17232041, exp. date Aug-25 17232396, exp. date Nov-25 17232406, exp. date Nov-25 17232410, exp. date Nov-25 17232490, exp. date Nov-25 17240326, exp. date Jan-26 17240327, exp. date Jan-26 17240383, exp. date Feb-26 17240395, exp. date Feb-26 17241863, exp. date Oct-26 17241869, exp. date Oct-26 17241870, exp. date Oct-26 17231256, exp. date May-25 17231386, exp. date May-25 17231387, exp. date May-25 17231407, exp. date May-25 17231417, exp. date May-25 17231418, exp. date May-25 17231754, exp. date Jul-25 17240085, exp. date Dec-25 17240117, exp. date Dec-25 17240131, exp. date Dec-25"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0435-2020", "product_description": "iSolutions Nano Tears XP Clear Emollient Lubricant Gel Drops Moderate Sterile, 1/3 FL OZ (10 mL), Mfd.  By: Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-143-10", "product_quantity": "12,716 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17366 12/19   18103 /20   18173 7/20"}, {"status": "Terminated", "city": "Gardena", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67265", "recalling_firm": "HUMAN SCIENCE FOUNDATION", "address_1": "13722 Harvard Pl", "address_2": "N/A", "postal_code": "90249-2527", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1327-2014", "product_description": "PRO ArthMax Dietary Supplement tablets, 750 mg, 120 count bottles, Distributed by Human Science Foundation, Los Angeles, CA", "product_quantity": "24,268 bottles", "reason_for_recall": "Marketed without an Approved NDA/ANDA; FDA analysis found the product to contain Chlorzoxazone, Nefopam, Diclofenac, Ibuprofen, Naproxen, and Indomethacin", "recall_initiation_date": "20140113", "center_classification_date": "20140519", "termination_date": "20140918", "report_date": "20140528", "code_info": "Lot# 220113; Exp. 01/16   Lot# 800213; Exp. 03/16  Lot# U133000; Exp. 04/16  Lot# U143200; Exp. 08/16  Lot# YJK015311; Exp. 10/16"}, {"status": "Ongoing", "city": "North Bergen", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M003"], "brand_name": ["PERIGIENE"], "generic_name": ["ANTIMICROBIAL DRUG PRODUCT"], "manufacturer_name": ["Dermarite Industries LLC"], "product_ndc": ["61924-198"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLOROXYLENOL"], "rxcui": ["436367", "1549631"], "spl_id": ["2888063b-6f40-9359-e063-6394a90a6a3c"], "spl_set_id": ["4f6e8610-f474-450e-a385-eaea58f649c8"], "package_ndc": ["61924-198-08", "61924-198-01"], "is_original_packager": [true], "upc": ["0714196198082"], "unii": ["0F32U78V2Q"]}, "product_type": "Drugs", "event_id": "97277", "recalling_firm": "DermaRite Industries, LLC", "address_1": "7777 W Side Ave", "address_2": "N/A", "postal_code": "07047-6436", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0613-2025", "product_description": "PeriGiene, Health Care Antiseptic, (Chloroxylenol 0.5%) 222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-198-08", "product_quantity": "5,703 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.", "recall_initiation_date": "20250717", "center_classification_date": "20250902", "report_date": "20250910", "code_info": "Lot #: 31013A, Exp. Date 11/2025; 40345A, 40355A, Exp. Date 4/2026; 40571A, 40580A, Exp. Date 6/2026; 40587A, 40591A, Exp. Date 7/2026; 40870.1, 40877.1, Exp. Date 10/2026; 41093A, Exp. Date 12/2026; 50072A, 50079A, Exp. Date 1/2027"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1024-2023", "product_description": "CARDIOPLEGIA SOLUTION, 48 mEq K, Induction 4:1 in Ringer's, High Potassium, IV Bag,  total volume = 522.8 mL, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0206-1", "product_quantity": "308 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-253951, Exp. 7/20/2023; 36-254912, Exp. 7/22/2023; 36-255215, 36-255216, Exp. 7/23/2023"}, {"country": "United States", "city": "Orchard Park", "address_1": "707 Sterling Drive", "reason_for_recall": "Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of sterility controls.", "address_2": "", "product_quantity": "", "code_info": "Stock No: 1096; Case UPC: 3 10742 91096 (4); Item UPC 3 10742 01096 1", "center_classification_date": "20140128", "distribution_pattern": "Nationwide and Puerto Rico", "state": "NY", "product_description": "ROHTO Dry Eye, hydra, Lubricant Eye Drops, Sterile, Net. Wt. 0.4 FL OZ (13 mL).  UPC 3 10742  01096 1,  Manufactured by Rohto-Mentholatum (Vietnam) Co., Ltd. for The Mentholatum Company, Orchard Park, NY 14127.   Made in Vietnam.", "report_date": "20140205", "classification": "Class II", "openfda": {}, "recalling_firm": "The Mentholatum Co.", "recall_number": "D-1039-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "67314", "termination_date": "20180601", "more_code_info": "", "recall_initiation_date": "20140116", "postal_code": "14127", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["ALTALUBE"], "generic_name": ["MINERAL OIL AND PETROLATUM"], "manufacturer_name": ["Altaire Pharmaceuticals Inc."], "product_ndc": ["59390-198"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["MINERAL OIL", "PETROLATUM"], "rxcui": ["579996", "1088146"], "spl_id": ["0c0e9c0d-6205-e63b-e063-6294a90ac0d9"], "spl_set_id": ["eb65004c-c3a7-4079-bd75-f2857d30c68a"], "package_ndc": ["59390-198-50"], "is_original_packager": [true], "unii": ["T5L8T28FGP", "4T6H12BN9U"]}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0418-2020", "product_description": "ActivEyes Sterile Altalube Ointment, Net Wt 1/8 oz (3.5g), NDC 59390-198-50", "product_quantity": "161077 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "RJH 10/20 1/10/2018   RLL 12/20 8/22/2018   SGH 07/21 8/23/2018   SIF 09/21 10/16/2018   SKC 11/21 12/12/2018   TCG 03/22"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204022"], "brand_name": ["ROPINIROLE"], "generic_name": ["ROPINIROLE"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-232", "16729-233", "16729-234", "16729-235", "16729-236", "16729-237", "16729-238"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ROPINIROLE HYDROCHLORIDE"], "rxcui": ["283858", "312845", "312846", "312847", "312849", "314208", "562704"], "spl_id": ["23980eef-2eb5-2b74-e063-6394a90a68ac"], "spl_set_id": ["4a2a5b63-5b14-6975-e054-00144ff8d46c"], "package_ndc": ["16729-232-01", "16729-233-01", "16729-234-01", "16729-235-01", "16729-236-01", "16729-237-01", "16729-238-01"], "is_original_packager": [true], "unii": ["D7ZD41RZI9"], "upc": ["316729232012"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0425-2023", "product_description": "rOPINIRole Tablets USP 0.25 mg*, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA. NDC 16729-232-01, UPC 3 16729 23201 2;", "product_quantity": "139,332 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: P2102086, Exp. Date 3/31/2023; P2105094, P2105095, P2105097, P2105096, P2105093, Exp. Date 7/31/2023; P2106490, P2106491, P2106493, P2106492, P2106494, Exp. Date 9/30/2023; P2201069, P2201068, P2201067, Exp. Date 1/31/2024; P2203516, Exp. Date 5/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211143"], "brand_name": ["METOPROLOL SUCCINATE"], "generic_name": ["METOPROLOL SUCCINATE ER TABLETS"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-590", "67877-591", "67877-592", "67877-593"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METOPROLOL SUCCINATE"], "rxcui": ["866412", "866419", "866427", "866436"], "spl_id": ["7b6e362b-e8bc-45ee-b369-7109fb60adeb"], "spl_set_id": ["58441cd3-6043-4bb8-adab-1b32a203bfb2"], "package_ndc": ["67877-590-30", "67877-590-60", "67877-590-01", "67877-590-05", "67877-590-10", "67877-591-30", "67877-591-60", "67877-591-01", "67877-591-05", "67877-591-10", "67877-592-30", "67877-592-60", "67877-592-01", "67877-592-05", "67877-592-10", "67877-593-30", "67877-593-60", "67877-593-01", "67877-593-05", "67877-593-10"], "is_original_packager": [true], "unii": ["TH25PD4CCB"]}, "product_type": "Drugs", "event_id": "91442", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0170-2023", "product_description": "Metoprolol Succinate Extended-Release Tablets, USP 50 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany NJ 07054, NDC 67877-591-01.", "product_quantity": "6,336 bottles", "reason_for_recall": "Failed Dissolution Specification", "recall_initiation_date": "20230105", "center_classification_date": "20230120", "termination_date": "20240815", "report_date": "20230201", "code_info": "Lot #: 21142633, Exp 03/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77777", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1002-2017", "product_description": "Diltiazem 125 mg in 0.9% Sodium Chloride, 1 mg per mL, Total Volume 125 mL Single Dose Container bag, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR 72205 (877) 550-5059; NDC: 70004-0541-35.", "product_quantity": "120 bags", "reason_for_recall": "Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170725", "termination_date": "20191030", "report_date": "20170802", "code_info": "Lot: 20170707@54, BUD: 10/4/2017"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71104", "recalling_firm": "Wockhardt Usa Inc.", "address_1": "20 Waterview Blvd Ste 3", "address_2": "N/A", "postal_code": "07054-1271", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide including Puerto Rico.", "recall_number": "D-1271-2015", "product_description": "Metoprolol Succinate Extended-Release Tablets, USP, 50 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-0735-02), B) 500 Count Bottles (NDC: 64679-0735-03), C) 4000 Count Pouches, For Repacking Only (NDC: 64679-0735-08), and D) 12 x 30 Tablet Dispenser Pack Cartons (NDC: 64679-0735-09), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.", "product_quantity": "A) 136,839 Bottles, B) 37,184 Bottles, C) 309 Pouches, and D) 9,764 Cartons.", "reason_for_recall": "CGMP Deviations: Firm did not adequately investigate customer complaints.", "recall_initiation_date": "20150422", "center_classification_date": "20150717", "termination_date": "20180509", "report_date": "20150729", "code_info": "A) Lot #: LN10967, Expiry: 4/30/2015; Lot #: LN10968, Expiry: 4/30/2015; Lot #: LN10969, Expiry: 4/30/2015; Lot #: LN11076, Expiry: 4/30/2015; Lot #: LN11077, Expiry: 4/30/2015; Lot #: LN11078, Expiry: 4/30/2015; Lot #: LN11126, Expiry: 5/31/2015; Lot #: LN11127, Expiry: 5/31/2015; Lot #: LN11326, Expiry: 6/30/2015; Lot #: LN11330, Expiry: 6/30/2015; Lot #: LN11331, Expiry: 6/30/2015; Lot #: LN11335, Expiry: 7/31/2015. B) Lot #: LN11093, Expiry: 4/30/2015; Lot #: LN11094, Expiry: 4/30/2015; Lot #: LN11095, Expiry: 4/30/2015; Lot #: LN11096, Expiry: 4/30/2015; Lot #: LN11097, Expiry: 4/30/2015; Lot #: LN11101, Expiry: 5/31/2015; Lot #: LN11102, Expiry: 5/31/2015; Lot #: LN11103, Expiry: 5/31/2015; Lot #: LN11107, Expiry: 5/31/2015; Lot #: LN11108, Expiry: 5/31/2015; Lot #: LN11131, Expiry: 5/31/2015; Lot #: LN11132, Expiry: 5/31/2015; Lot #: LN11133, Expiry: 5/31/2015; Lot #: LN11203, Expiry: 5/31/2015; Lot #: LN11204, Expiry: 5/31/2015; Lot #: LN11325, Expiry: 6/30/2015.  C) Lot #: LN10988, Expiry: 4/30/2015.  D) Lot #: LN11192, Expiry: 5/31/2015; Lot #: LN11197, Expiry: 5/31/2015; Lot #:LN11198, Expiry: 5/31/2015."}, {"status": "Terminated", "city": "Lenoir", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA211091"], "brand_name": ["SODIUM BICARBONATE"], "generic_name": ["SODIUM BICARBONATE"], "manufacturer_name": ["Civica"], "product_ndc": ["72572-740"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM BICARBONATE"], "rxcui": ["1868486"], "spl_id": ["98efb401-5361-41ff-979a-6857768a144c"], "spl_set_id": ["a10fdfbc-94a0-49ab-b26c-de1df042bc89"], "package_ndc": ["72572-740-20", "72572-740-25"], "is_original_packager": [true], "upc": ["0372572740258"], "unii": ["8MDF5V39QO"]}, "product_type": "Drugs", "event_id": "91197", "recalling_firm": "Exela Pharma Sciences LLC", "address_1": "1245 Blowing Rock Blvd", "address_2": "N/A", "postal_code": "28645-3618", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0080-2023", "product_description": "8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx Only, Mfd for: Civica, Inc. Lehi, Utah 84043, Mfd by: Exela Pharma Sciences, LLC, Lenoir, NC 28645, Carton NDC 72572-740-20, vial NDC 72572-740-1.", "product_quantity": "37,320 vials", "reason_for_recall": "Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.", "recall_initiation_date": "20221128", "center_classification_date": "20221213", "termination_date": "20251010", "report_date": "20221221", "code_info": "Lot: P0001490 Exp. 12/2023"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020309"], "brand_name": ["MAGNESIUM SULFATE IN WATER"], "generic_name": ["MAGNESIUM SULFATE IN WATER"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-2050", "0409-6730", "0409-6729", "0409-4121", "0409-3164", "0409-5239"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["MAGNESIUM SULFATE HEPTAHYDRATE"], "rxcui": ["829734", "1658259", "1658262", "1658264", "1658265"], "spl_id": ["7c96de7c-c75b-487c-8534-0b0b2de9cdea"], "spl_set_id": ["22ca78b4-f5a3-4144-cf89-5f633acf1e6d"], "package_ndc": ["0409-6730-11", "0409-6730-13", "0409-6730-50", "0409-6730-60", "0409-6729-41", "0409-6729-23", "0409-6729-21", "0409-6729-03", "0409-6729-31", "0409-6729-09", "0409-6729-11", "0409-6729-24", "0409-4121-01", "0409-4121-50", "0409-2050-01", "0409-2050-20", "0409-3164-01", "0409-3164-12", "0409-5239-01", "0409-5239-60"], "is_original_packager": [true], "unii": ["SK47B8698T"]}, "product_type": "Drugs", "event_id": "62053", "recalling_firm": "Hospira, Inc.", "address_1": "600 N Field Dr Bldg J45", "address_2": "N/A", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1390-2012", "product_description": "Magnesium Sulfate in Water for Injection, 40 mg/mL (0.325 mEq Mg++/mL), 2 g total, 50 mL Flexible Container, Rx only, Hospira, Inc., Lake Forest, IL 60045; NDC 0409-6729-24.", "product_quantity": "164,568 containers", "reason_for_recall": "Superpotent (Single Ingredient) Drug: Above specification assay results for percentage of magnesium sulfate.", "recall_initiation_date": "20120405", "center_classification_date": "20120620", "termination_date": "20130808", "report_date": "20120627", "code_info": "Lot #: 04510KL*, Exp 01OCT2012; *lot number may have 01 or 02 following it"}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "21000 mL in Vials", "code_info": "Lot #: 151130-64, BUD: 05/28/16,  Lot #: 151228-22, BUD: 06/25/16,  Lot #: 160210-29, BUD: 08/08/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "MINOXIDIL 0.5% W/PRES. (BENZYL ETOH 2%), 10ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1226-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64233", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "N/A", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-193-2013", "product_description": "Terazosin Hydrochloride Capsules, 2 mg, packaged in a) 100-count bottles (NDC 0093-4337-01); and b) 1000-count bottles (NDC 0093-4337-10), Rx only, Manufactured in India By: Intas Pharmaceuticals Ltd., Ahmedabad, Gujarat, India - 382 210; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA  18960.", "product_quantity": "3,913 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Recall is being conducted due to a foreign capsule found in one bottle.", "recall_initiation_date": "20130123", "center_classification_date": "20130308", "termination_date": "20140403", "report_date": "20130320", "code_info": "Lot # N03029, Exp 03/14", "more_code_info": ""}, {"status": "Terminated", "city": "Southern Pines", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70656", "recalling_firm": "Health Innovations Pharmacy, Inc", "address_1": "295 Pinehurst Ave Bldg 2", "address_2": "N/A", "postal_code": "28387-7051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "NC", "recall_number": "D-1011-2015", "product_description": "Progest 200 mg/1 mL Cream, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.", "recall_initiation_date": "20150212", "center_classification_date": "20150508", "termination_date": "20170720", "report_date": "20150520", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0026-2023", "product_description": "ACETYLCYSTEINE OPTH 10% Solution, 15 mL droptainers, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "1 droptainer", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 66895, BUD: 11/19/2022"}, {"country": "United States", "city": "New Brunswick", "address_1": "755 and 769 Jersey Ave", "reason_for_recall": "Does not meet monograph: product exhibits lead levels in excess of the USP monograph limits.", "address_2": "", "product_quantity": "14,000 grams", "code_info": "Lot # 2EH0257", "center_classification_date": "20160810", "distribution_pattern": "US: MA, TN, GA, MO and Canada", "state": "NJ", "product_description": "Zinc Acetate, Crystal, USP, packaged in 500 gram bottles, Spectrum Chemical MFG, CORP., New Brunswick, NJ 08901", "report_date": "20160817", "classification": "Class II", "openfda": {}, "recalling_firm": "Spectrum Laboratory Products, Inc.", "recall_number": "D-1456-2016", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "74888", "termination_date": "20170407", "more_code_info": "", "recall_initiation_date": "20160801", "postal_code": "08901-3605", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81311", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US and Puerto Rico", "recall_number": "D-0095-2019", "product_description": "Meropenem for Injection, USA (I.V.), 1 gram/vial, 25 vials per carton, Sterile, Rx Only, Manufactured for: Hospira, Inc., Lake Forest, IL 60045, USA.  NDC carton: 0409-3506-01; NDC vial: 0409-3506-11", "product_quantity": "71,075 vials", "reason_for_recall": "Lack of assurance of sterility: loss of container integrity.", "recall_initiation_date": "20180920", "center_classification_date": "20181024", "termination_date": "20220917", "report_date": "20181031", "code_info": "Lot: 609G047, EXP 10/2018"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-976-2013", "product_description": "MAGNESIUM CHLORIDE HEXAHYDRATE 20% INJECTABLE, all presentations, FOR INTRAVENO and SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "01212013@10, 03042013@26, 04032013@23, 04222013@26, 06052013@12, 06122013@27, 07032013@7, 07092013@21, 07152013@40, 07262013@21", "more_code_info": ""}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "560", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "HYDROmorphone HCI 0.4mg/mL in 0.9% Sodium Chloride 25 mL fill in a 30 mL BD syringe;, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0815-67", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1305-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82398", "recalling_firm": "Advanced Pharma Inc.", "address_1": "9265 Kirby Dr", "address_2": "N/A", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1031-2019", "product_description": "Heparin 5,000 Units/5mL (1,000 Units per mL) Injectable Solution, 5,000 Units in 0.9% Sodium Chloride, QS 5 mL Sterile single use syringe, NDC: 42852-739-67 Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404", "product_quantity": "1440 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190313", "center_classification_date": "20190321", "termination_date": "20200114", "report_date": "20190327", "code_info": "Lot: 10/25/18 4819 73967S Exp. 3/24/2019"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0036-2022", "product_description": "DEXPANTHENOL 250MG/ML INJ SOLN, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "22 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03092015@29, 6/7/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Fentanyl 5,000 mcg/ml Intrathecal Solution, Sterile - Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1495-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Davie", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201089"], "brand_name": ["DICLOFENAC SODIUM AND MISOPROSTOL"], "generic_name": ["DICLOFENAC SODIUM AND MISOPROSTOL"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-0397", "0591-0398"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DICLOFENAC SODIUM", "MISOPROSTOL"], "rxcui": ["857706", "1359105"], "spl_id": ["03f24a4c-0fe7-446a-b64d-a7c6b12cae0f"], "spl_set_id": ["df8b8660-0c24-4848-8bea-c1b935090c66"], "package_ndc": ["0591-0397-19", "0591-0397-60", "0591-0398-60"], "is_original_packager": [true], "nui": ["N0000175785", "M0017811"], "pharm_class_epc": ["Prostaglandin E1 Analog [EPC]"], "pharm_class_cs": ["Prostaglandins E, Synthetic [CS]"], "unii": ["0E43V0BB57", "QTG126297Q"], "upc": ["305910398606"]}, "product_type": "Drugs", "event_id": "69495", "recalling_firm": "Actavis Laboratories, FL, Inc.", "address_1": "4955 Orange Dr", "address_2": "N/A", "postal_code": "33314-3902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide including Puerto Rico.", "recall_number": "D-0258-2015", "product_description": "Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only. Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC: 0591-0398-60, UPC 3 05910 39860 6.", "product_quantity": "5,451 Bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Presence of split or broken tablets.", "recall_initiation_date": "20140926", "center_classification_date": "20141121", "termination_date": "20150616", "report_date": "20141203", "code_info": "Lot # 694320A, Expiry: 02/28/2015.", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ACYCLOVIR, Tablet, 800 mg may have potentially been mislabeled as the following drug:\t  PANTOPRAZOLE SODIUM DR, Tablet, 20 mg, NDC 64679043304, Pedigree: AD70690_4, EXP: 5/29/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "ACYCLOVIR, Tablet, 800 mg has the following codes:   Pedigree: AD70629_1, EXP: 5/29/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ACYCLOVIR, Tablet, 800 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093894701.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-858-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "B5026 Exp 9/30/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Estradiol Cypionate 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-727-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "10", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Midazolam HCl 1mg/mL in 0.9% Sodium Chloride, 50 mL Intravia bag, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0989-41", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1341-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Berkeley", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90289", "recalling_firm": "Valor Compounding Pharmacy, Inc DBA  Valor Compounding Pharmacy", "address_1": "2461 Shattuck Ave", "address_2": "", "postal_code": "94704", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "CA", "recall_number": "D-1167-2022", "product_description": "Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704,", "product_quantity": "1,966 mLs in 12 oz; 2 oz; 16 oz and 6 oz bottles", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20220415", "center_classification_date": "20220627", "termination_date": "20221107", "report_date": "20220615", "code_info": "Lot #: 03312022@29, BUD: 6/10/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090617"], "brand_name": ["METOPROLOL SUCCINATE"], "generic_name": ["METOPROLOL SUCCINATE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-466", "55111-467"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METOPROLOL SUCCINATE"], "rxcui": ["866427", "866436"], "spl_id": ["a453a5a1-ddeb-6093-ff84-3d5c822b8847"], "spl_set_id": ["90594d68-87f2-5f75-2d8a-1629f88ba8a9"], "package_ndc": ["55111-466-30", "55111-466-60", "55111-466-01", "55111-466-05", "55111-466-79", "55111-466-78", "55111-467-30", "55111-467-60", "55111-467-01", "55111-467-05", "55111-467-79", "55111-467-78"], "is_original_packager": [true], "upc": ["0355111466017", "0355111467014"], "unii": ["TH25PD4CCB"]}, "product_type": "Drugs", "event_id": "67293", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "LA, MI, MO, MS & OH", "recall_number": "D-1080-2014", "product_description": "Dr. Reddy's Metoprolol Succinate Extended-Release Tablets USP, 50 mg 100 tablets Rx Only Mfd. By: Dr. Reddy's Laboratories Limited Bachepalli -500 090 INDIA  NDC 55111-467-01", "product_quantity": "8,592 bottles", "reason_for_recall": "Failed Dissolution Specification; 12-Month stability interval.", "recall_initiation_date": "20131213", "center_classification_date": "20140206", "termination_date": "20150212", "report_date": "20140212", "code_info": "Lot # C207420 and C207416", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-865-2015", "product_description": "Procaine Penicillin G active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1000 grams", "reason_for_recall": "Stability Data Does Not Support Expiry: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged without data to support the printed expiry date.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Olive Branch", "address_1": "1 & 2", "reason_for_recall": "Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.", "address_2": "154 Downing Street", "product_quantity": "Unknown", "code_info": "Lot #: 15817VP-01, 15817VP-02, 15817VP-03, Exp 9/30/2019; 15818001, Exp 3/31/2020.", "center_classification_date": "20180907", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "state": "MS", "product_description": "Levothyroxine and Liothyronine (Thyroid Tablets, USP), 2 grain (120 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-158-04.", "report_date": "20180829", "classification": "Class I", "openfda": {}, "recalling_firm": "Westminster Pharmaceuticals LLC", "recall_number": "D-1182-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80719", "termination_date": "20200603", "more_code_info": "", "recall_initiation_date": "20180803", "postal_code": "38654", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0784-2019", "product_description": "Dr. King's SafeCare Rx CA Miasm, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955030027, NDC 57955-0300-2", "product_quantity": "146 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 033016H Exp. 03/19; 121216D Exp. 12/19"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62664", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distribution was nationwide and to Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-103-2013", "product_description": "Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01,   Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "16,548/100-tablet bottles", "reason_for_recall": "Subpotent; 9-month stability interval", "recall_initiation_date": "20120725", "center_classification_date": "20121221", "termination_date": "20131114", "report_date": "20130102", "code_info": "Lot 1094098, exp. date 9/2012"}, {"status": "Terminated", "city": "Gulfport", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83835", "recalling_firm": "GCP Laboratories Inc", "address_1": "3600 25th Ave", "address_2": "N/A", "postal_code": "39501-6922", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in MI and further distributed Nationwide.", "recall_number": "D-0126-2020", "product_description": "Major Infants' Gas Relief Drops, Simethicone Oral Suspension USP, 1 FL OZ (30 mL) bottle, Distributed by: Major Pharmaceuticals 17177 N Laurel Park Drive, Suite 233 Livonia, MI 48152 USA. NDC 0904-5894-30", "product_quantity": "31,392 30 mL bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Product.", "recall_initiation_date": "20190918", "center_classification_date": "20191007", "termination_date": "20210205", "report_date": "20191016", "code_info": "Lot: WBD003 Exp. 03/21"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83875", "recalling_firm": "Sandoz, Inc", "address_1": "506 Carnegie Ctr Ste 400", "address_2": "N/A", "postal_code": "08540-6243", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0127-2020", "product_description": "Sandoz Ranitidine Hydrochloride Capsules 150mg 60 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ  Product of India  NDC 0781-2855-60", "product_quantity": "100,314 bottles", "reason_for_recall": "CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).", "recall_initiation_date": "20190923", "center_classification_date": "20191007", "termination_date": "20230714", "report_date": "20191016", "code_info": "HC9266 4/30/2020   HD1865 4/30/2020  HP9441 9/30/2020  JK7994 8/31/2021  JK8659 8/31/2021"}, {"status": "Ongoing", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Institutional Inc."], "product_ndc": ["51079-440", "51079-444", "51079-441", "51079-442", "51079-443", "51079-445"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "966220", "966221", "966222", "966224", "966225"], "spl_id": ["3a864332-4c4d-08a5-e063-6294a90aaaff"], "spl_set_id": ["5723c7a7-2a1d-4ab6-bf39-b2165ae781a6"], "package_ndc": ["51079-440-01", "51079-440-20", "51079-444-01", "51079-444-20", "51079-441-01", "51079-441-20", "51079-442-01", "51079-442-20", "51079-443-01", "51079-443-20", "51079-445-01", "51079-445-20"], "original_packager_product_ndc": ["0378-1803", "0378-1800", "0378-1805", "0378-1809", "0378-1813", "0378-1815"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95817", "recalling_firm": "Mylan Institutional, Inc.", "address_1": "1718 Northrock Ct", "address_2": "", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0131-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.  NDC: 51079-442-20", "product_quantity": "2,835 cartons", "reason_for_recall": "Subpotent and Superpotent Drug", "recall_initiation_date": "20241119", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: 3115936, Exp. Date 07/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Central Islip", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211487"], "brand_name": ["HYDROCODONE BITARTRATE AND ACETAMINOPHEN"], "generic_name": ["HYDROCODONE BITARTRATE AND ACETAMINOPHEN"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-996", "31722-997"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "HYDROCODONE BITARTRATE"], "rxcui": ["856999", "857002"], "spl_id": ["d745e0ac-ee48-44c7-8430-8da0a69d2735"], "spl_set_id": ["ed6af366-753c-4f3b-a6a2-c9a183c50035"], "package_ndc": ["31722-996-01", "31722-996-05", "31722-997-01", "31722-997-05"], "is_original_packager": [true], "upc": ["0331722997010", "0331722996013"], "unii": ["362O9ITL9D", "NO70W886KK"]}, "product_type": "Drugs", "event_id": "89060", "recalling_firm": "Ascent Pharmaceuticals, Inc.", "address_1": "400 S Technology Dr", "address_2": "N/A", "postal_code": "11722-4402", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0276-2022", "product_description": "Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Manufactured by: Ascent Pharmaceuticals, Inc., Central Islip, NY 11722, NDC 31722-997-01.", "product_quantity": "9744 bottles", "reason_for_recall": "Product Mix-up", "recall_initiation_date": "20211119", "center_classification_date": "20211207", "termination_date": "20231206", "report_date": "20211215", "code_info": "Lot #: 21070817, Exp 6/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0694-2022", "product_description": "Lidocaine Ointment USP, 5%, Net Wt 35.44 g (1 1/4 oz) tube, Rx Only, Teligent Pharma, Inc., Buena, New Jersey 08310, NDC 52565-008-14.", "product_quantity": "100,256 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: 16389, Exp. 2/29/2024; 16452, Exp. 2/29/2024"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0239-2023", "product_description": "THIAMINE/RIBOFLA/NIACINAMI/DEXPANTH/PYRIDOX/HYDROXYCOBAL 25MG/25MG/25MG/25MG/25MG/20MG/ML (3ML VIAL) INJECTABLE THIAMINE/RIBOFLA/NIACINAMI/DEXPANTH/PYRIDOX/METHYLFOLATE/METHYLCOBAL 10MG/2.5MG/25MG/5MG/5MG/10MG/10MG/ML (1ML VIAL) INJECTABLE THIAMINE/RIBOFLAVIN/NIACINAMIDE/DEXPANTHENOL/PYRIDOXINE 50MG/1MG/100MG/3MG/2MG/ML (30ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221116@36 t20221121@42 t20221021@32", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0934-2020", "product_description": "Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 60 mcg/30 mg/2 mg/0.15mg/ml, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0550-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 12042019+53323, Exp 1/17/2020"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68967", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1580-2014", "product_description": "PAXIL (Paroxetine HCL) Tablets 10 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3663-3", "product_quantity": "", "reason_for_recall": "Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.", "recall_initiation_date": "20140324", "center_classification_date": "20140903", "termination_date": "20140923", "report_date": "20140910", "code_info": "Lot # 2ZP7113, Exp. 08/15", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73925", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0035-2017", "product_description": "fentaNYL Citrate, 10 mcg per 1 mL, in 0.9% Sodium Chloride, Preservative Free, 1 mL Total Volume in a syringe, For IV Use, Rx only, PharMEDium, Product code 2R3174.", "product_quantity": "8955 syringes", "reason_for_recall": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.", "recall_initiation_date": "20150717", "center_classification_date": "20161012", "termination_date": "20170623", "report_date": "20161019", "code_info": "Lot Numbers: 15118074M, 15120007M, 15124007M, 15127060M, 15132006M, 15132039M, 15138059M, 15139012M, 15139051M, 15140003M, 15141067M, 15146006M, 15148075M, 151730112M, 151730155M, 151740205M, 151880329M, 151930020M, 151930026M, Exp between 07/15/15-10/12/15"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Papaverine 12mg/phent 1mg/Pros 9mcq/ml", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1127-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0076-2015", "product_description": "Dexamethasone sodium phosphate 4 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "110 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 04032014@13, Exp 9/30/2014; 06042014@5, Exp 12/1/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0084-2020", "product_description": "Phenylephrine HCl 1.5% (15 mg/mL) Lidocaine HCl 1% (10 mg/mL) (PF) (Sulfite Free) Ophthalmic Injection, 3 mL Single Dose Syringe, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678441", "product_quantity": "825 syringe", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-050-2014", "product_description": "B-Complex 100 30ml (PF), Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "35 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1379-2022", "product_description": "DOCTOR DANDRUF 2N1 SHAMP CLN APL 13.5FLOZ SKU 2005726   SUAVE 2N1 MENS CC ANTI DNDRF SHMP 28 FLOZSKU 2006512   MANE N TAIL 2 IN 1 ANTI DANDRUFF 12 FL OZ SKU 2024652   HEAD AND SOULDERS 2N1 SMOOTH SILKY 12.8 FL OZ SKU 2097272   DOCTOR MED DANDRUFF TREAT 11 FL OZ SKU 2005531   HEAD AND SOULDERS CLASSIC CLEAN SH 13.5 OZ SKU 2099110   DOCTOR DANDRUF 2IN1 SHAM DRYSCLP 13.5FL OZ SKU 2038805   HEAD AND SOULDERS 2IN 1 DRY SCALP 13.5 FL OZ SKU 2038366   HEAD AND SOULDERS 2IN 1 DRY SCALP SHAMPOO 23.7 FLOZ SKU 2005504   DOCTOR DANDRUFF 2N1 SHAMPOO 13.5FL OZ SKU 2038806   DOCTOR SHAMPOO T GEL 8.5 FL OZ SKU 2038935   DOCTOR 2N1 DANDRUFF CLSC 23.7FLOZ SKU 2005121 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 2005726; 2006512; 2024652; 2097272; 2005531; 2099110; 2038805; 2038366; 2005504; 2038806; 2038935; 2005121", "more_code_info": ""}, {"status": "Terminated", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210757"], "brand_name": ["COLCHICINE"], "generic_name": ["COLCHICINE"], "manufacturer_name": ["Granules Pharmaceutical Inc."], "product_ndc": ["70010-001"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["COLCHICINE"], "rxcui": ["1550940"], "spl_id": ["3836b9fe-5628-fe23-e063-6294a90aa475"], "spl_set_id": ["16d49c45-5b0a-a7fa-e063-6294a90a7320"], "package_ndc": ["70010-001-01", "70010-001-10", "70010-001-03"], "is_original_packager": [true], "upc": ["0370010001039"], "nui": ["N0000193949", "M0000713"], "pharm_class_epc": ["Alkaloid [EPC]"], "pharm_class_cs": ["Alkaloids [CS]"], "unii": ["SML2Y3J35T"]}, "product_type": "Drugs", "event_id": "96026", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0187-2025", "product_description": "Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 20151 NDC 70010-001-03", "product_quantity": "96 Bottles", "reason_for_recall": "Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.", "recall_initiation_date": "20241218", "center_classification_date": "20250107", "termination_date": "20250701", "report_date": "20250115", "code_info": "Lot#: GPC240763B, Exp. Date 6/17/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202557"], "brand_name": ["BUSPIRONE HYDROCHLORIDE"], "generic_name": ["BUSPIRONE HYDROCHLORIDE"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-200", "16729-203", "16729-289", "16729-201", "16729-202"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUSPIRONE HYDROCHLORIDE"], "rxcui": ["866018", "866083", "866090", "866094", "866111"], "spl_id": ["4092e48b-b3d6-abf3-e063-6394a90afe61"], "spl_set_id": ["3da22999-f5fb-49fd-acde-c3006598e985"], "package_ndc": ["16729-203-12", "16729-203-01", "16729-203-59", "16729-203-16", "16729-203-17", "16729-289-12", "16729-289-01", "16729-289-59", "16729-289-16", "16729-289-17", "16729-200-01", "16729-200-16", "16729-200-17", "16729-201-01", "16729-201-16", "16729-201-17", "16729-202-01", "16729-202-16", "16729-202-17"], "is_original_packager": [true], "upc": ["0316729289016", "316729200011", "316729200165"], "unii": ["207LT9J9OC"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0376-2023", "product_description": "BusPIRone Hydrochloride Tablets USP, 5 mg, Rx Only, Packaged as: a) 100 Tablets NDC 16729-200-01 UPC 3 16729 20001 1; b) 500 Tablets NDC 16729-200-16 UPC 3 16729 20016 5; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA", "product_quantity": "24,408 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a) P2200530, Exp. Date 12/31/2024; b) P2105583, Exp. Date 6/30/2024;", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0080-2020", "product_description": "NORepinephrine in 0.9% Sodium Chloride (PF), 250 mL IV bag, 4 mg/250 mL (0.016 mg/mL),  Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487, NDC 3321678032", "product_quantity": "528 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "2", "code_info": "C5505 Exp 9/5/13 and C5107 Exp 9/7/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Detomidine 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-717-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "129 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  02252015@14, 5/26/2015; 04012015@2, 6/30/2015; 04272015@30, 7/26/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Fentanyl 950 mcg/ml + Bupivacaine 5 mg/ml Intrathecal Solution, Sterile-Preservative Free,The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1488-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0257-2020", "product_description": "S-VITAMIN D3 10,000 IU/ML OIL MDV INJ, Rx Only, a) 5ml b) 10 ML glass vial. Red Mountain Compounding Rx.", "product_quantity": "16x5 and 10 ml glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:  S04092019DT@16, Exp 8/9/19; S05012019DT@08, Exp 9/1/19; S05152019DT@01, Exp 9/15/19; S06112019DH@18, Exp 10/11/19; S06122019DT@06, Exp 10/12/19; S06192019DT@10, Exp 10/19/19; s07092019dt@16, Exp 11/9/19; S07242019DH@10, Exp 11/24/19"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0516-2018", "product_description": "Phentolamine Mesylate USP for prescription compounding, packaged in a) 1g (NDC 58597-8077-3); b) 5g (NDC 58597-8077-4); c) 500g (NDC 58597-8077-7), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "6000 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 080315-1, Exp. 04/05/2018; b) 080315-1, Exp. 04/05/2018, c) 080315-1, Exp. 04/05/2018."}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0792-2019", "product_description": "Dr. King's SafeCare Rx Artery/Cholesterol/BP, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955006428, NDC 57955-0064-2", "product_quantity": "544 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 092915G Exp. 09/18; 041416F Exp. 04/19"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1221-2020", "product_description": "Progesterone/Natacream 20 mg/2% mL Cream 60 gm jar, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 jar", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45233 Discard by: 9/15/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1704-2019", "product_description": "SODIUM BICARBONATE 8.4% (1 MEQ/ML) INJ SOLN (PFV), 50 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0957-50", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0108-2015", "product_description": "Opthalmic ointment base ointment packaged in a white ointment tube, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "30 gm", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 07312014@27, Exp 10/29/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Jewett", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71187", "recalling_firm": "Bee Extremely Amazed LLC", "address_1": "85205 Sportsmans Club Rd", "address_2": "N/A", "postal_code": "43986-9794", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-1146-2016", "product_description": "SlimeX-15 Capsules, 15 mg, 30-count bottles, Marketed by: Signature Pharmaceuticals Ltd. MUMBAI-400-030 Manufactured in India by: HAB Pharmaceuticals & Research Limited 10-Pharma City, SIDCUL, Selaqui, Dehradun, 248 197", "product_quantity": "N/A", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared sibutramine, an appetite suppressant that was withdrawn from the US market for safety reasons, making it an unapproved drug.", "recall_initiation_date": "20151215", "center_classification_date": "20160706", "termination_date": "20200423", "report_date": "20160713", "code_info": "All lots"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0214-2019", "product_description": "Testosterone Cypionate/Proprinate 200 mg/10 mg/1 mL 30 mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1745-30", "product_quantity": "580 vials and 30000 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 02272018:63/A Discard by: 2/22/2019; 08162018:63/A Discard by: 4/30/2019; 10092017:30 Discard by: 10/1/2018; 02272018:63 Discard by: 2/22/2019; 08162018:63 Discard by: 4/30/2019"}, {"country": "United States", "city": "Plattsburgh", "address_1": "661 State Route 3", "reason_for_recall": "Labeling: Label Mix-Up: FDA tested samples of API from Medisca, labeled as to contain L-Citrulline, and results revealed no L-Citrulline was present. Levels of N-acetyl-leucine were found instead.", "address_2": "Unit C", "product_quantity": "25 g: 15 bottles, 100 g: 153 bottles; 500 g: 18 bottles, 1 kg: 24 bottles", "code_info": "Lot #s: 95482/A, 95482/B, 95482/C, 95482/D, 96453/A, 96453/B, 96453/C, and 96453/D, Exp. 10/31/2014", "center_classification_date": "20160217", "distribution_pattern": "Nationwide and Australia", "state": "NY", "product_description": "CITRULLINE (L) in 25 g, 100 g, 500 g and 1 kg plastic bottles, White crystals or crystalline powder, odorless, For Use and distribution in prescription compounding, manufacturing, processing, or repackaging only in accordance with FDA regulations and applicable law, Packaged by Medisca Inc. Plattsburgh, NY 12901, USA, NDC #s: 38779-1186-4 (25 g), 38779-1186-5 (100 g), 38779-1186-8 (500 g), 38779-1186-9 (1 kg).", "report_date": "20160224", "classification": "Class I", "openfda": {}, "recalling_firm": "Medisca Inc", "recall_number": "D-0674-2016", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "67531", "termination_date": "20160217", "more_code_info": "", "recall_initiation_date": "20140214", "postal_code": "12901-6531", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tarrytown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83417", "recalling_firm": "Medtech Products, Inc.", "address_1": "660 White Plains Rd Ste 250", "address_2": "N/A", "postal_code": "10591-5171", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico, St. Michael, Barbados, Guyana, St. Johns, Antigua and Barbuda, Kingston 5, and Jamaica.", "recall_number": "D-1828-2019", "product_description": "Clear Eyes Assorted Sidekick Floor Stand Display; each display contains 6 each of a) Clear eyes REDNESS RELIEF (Glycerin 0.25%, Naphazoline hydrochloride 0.12%) eye drops, 0.5 FL OZ (15 mL) bottle (UPC 6 78112 25415 6); b) Clear eyes MAXIMUM REDNESS RELIEF (Glycerin 0.5%, Naphazoline hydrochloride 0.03%), 0.5 FL OZ (15 mL) bottle (UPC 6 78112 66577 8); and c) Clear eyes MAXIMUM ITCHY EYE RELIEF (Glycerin 0.25%, Naphazoline hydrochloride 0.012%, Zinc Sulfate 0.25%), 0.5 FL OZ (15 mL) bottle (UPC 6 78112 65920 3); Distributed by Medtech Products Inc., Tarrytown, NY  10591, A Prestige Brands Company, case UPC 00678112106905.", "product_quantity": "25,992 bottles", "reason_for_recall": "CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.", "recall_initiation_date": "20190726", "center_classification_date": "20190816", "termination_date": "20210310", "report_date": "20190828", "code_info": "Lot #: Display 17E12A, Exp 09/19; lot and expiry for individual products within this display are captured in each individual product Code Information"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0226-2023", "product_description": "PAPAVERINE/PHENTOLAMINE 30MG/0.5MG/ML (1ML VIAL) INJECTABLE; PAPAVERINE/PHENTOLAMINE 30MG/1MG/ML (1ML VIAL) INJECTABLE; PAPAVERINE/PHENTOLAMINE 30MG/2MG/ML (1ML VIAL) INJECTABLE; PAPAVERINE/PHENTOLAMINE 30MG/3MG/ML (1ML VIAL) INJECTABLE; PAPAVERINE/PHENTOLAMINE 30MG/5MG/ML (1ML VIAL) INJECTABLE; Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221011@7 t20221020@34 t20221018@58 t20221013@15 t20221104@39", "more_code_info": ""}]